Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.

le Lennard, M S
Foilsithe 1991

Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

le Bax, N D, Lennard, M S, Tucker, G T
Foilsithe 1981

Effect of beta-blockers on thyroid hormone.

le Bax, N D, Lennard, M S, Tucker, G T
Foilsithe 1980

Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.

le Lennard, M S, Silas, J H, Freestone, S, Trevethick, J
Foilsithe 1982

Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards

le Davies, S J C, Eayrs, S, Pratt, P, Lennard, M S
Foilsithe 2004

Variable contribution of CYP2D6 to the N-Dealkylation of S-(-)-propranolol by human liver microsomes

le ROWLAND, K., WYNNE ELLIS, S., LENNARD, M. S., TUCKER, G. T.
Foilsithe 1996

Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics and first dose effect of prazosin.

le Lennard, M S, McGourty, J C, Silas, J H
Foilsithe 1988

Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.

le Silas, J H, Freestone, S, Lennard, M S, Ramsay, L E
Foilsithe 1985

Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.

le Freestone, S, Silas, J H, Lennard, M S, Ramsay, L E
Foilsithe 1982

Determination of metformin in biological samples.

le Lennard, M S, Casey, C, Tucker, G T, Woods, H F
Foilsithe 1978

Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians

le Simooya, O O, Sijumbil, G, Lennard, M S, Tucker, G T
Foilsithe 1998

Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices.

le Jackson, P R, Tucker, G T, Lennard, M S, Woods, H F
Foilsithe 1986

The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.

le Bax, N D, Tucker, G T, Lennard, M S, Woods, H F
Foilsithe 1985

The Journal moves online for submission and peer review

le Lennard, M S, Ritter, J M, Begg, E J, Tucker, G T
Foilsithe 2002

The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.

le McCourty, J C, Silas, J H, Tucker, G T, Lennard, M S
Foilsithe 1988

Cytochromes P450 mediating the N-demethylation of amitriptyline

le Ghahramani, P., Ellis, S. W., Lennard, M. S., Ramsay, L. E., Tucker, G. T.
Foilsithe 1997

Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.

le Otton, S V, Gillam, E M, Lennard, M S, Tucker, G T, Woods, H F
Foilsithe 1990

Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.

le Deacon, C S, Lennard, M S, Bax, N D, Woods, H F, Tucker, G T
Foilsithe 1981

Lack of effect of atenolol on antipyrine clearance.

le Tucker, G T, Bax, N D, Lennard, M S, Crewe, K, Woods, H F
Foilsithe 1982

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.

le Bloomer, J C, Woods, F R, Haddock, R E, Lennard, M S, Tucker, G T
Foilsithe 1992